# Differences in Malaria Infection Levels in HIV-infected Infants and Children Receiving PI- and NNRTI-based HAART

> **NCT00719602** · EARLY_PHASE1 · COMPLETED · sponsor: **International Maternal Pediatric Adolescent AIDS Clinical Trials Group** · enrollment: 105 (actual)

## Conditions studied

- HIV Infections
- Malaria

## Interventions

- **DRUG:** Lamivudine
- **DRUG:** Lopinavir/Ritonavir
- **DRUG:** Nevirapine
- **DRUG:** Zidovudine

## Key facts

- **NCT ID:** NCT00719602
- **Lead sponsor:** International Maternal Pediatric Adolescent AIDS Clinical Trials Group
- **Sponsor class:** NETWORK
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2016-09-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00719602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00719602, "Differences in Malaria Infection Levels in HIV-infected Infants and Children Receiving PI- and NNRTI-based HAART". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00719602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*